Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (4727)	1/13/1998 10:43:00 PM
From: Evan Dimmer	Read Replies (1) \| Respond to of 120523

How about VVUS? It reports earnings Thursday after the bell.

To: Jenna who wrote (4727)	1/13/1998 10:47:00 PM
From: LastShadow	Read Replies (1) \| Respond to of 120523

Watch List 1/14: Having made that summary in the previous post, one can either assume that this list will either be the greatest opportunity for shorting, or have some marginal validity... SYMBOL CLOSE CHANGE CHANGE % AAPL 19.500 1.250 6.85% ASND 28.625 1.687 6.26% CNTR 1.156 0.031 2.78% CTYS 0.594 0.094 18.75% GM 58.000 1.250 2.20% ORCL 19.187 1.125 6.23% VTSS 42.500 5.312 14.29% Still bullish on: DIMD 12.437 0.437 3.65% PAIR 18.062 1.062 6.25% PNF 6.437 0.562 9.57% PSIX 5.937 0.437 7.95% QCOM 48.687 1.625 3.45% UCMP 8.750 0.875 11.11% Still very long on IIT - HOWEVER, the last hour showed some weakness and I may exit in the morning to protect profits and reenter later intraday. I do still believe it is an excellent mid term hold though. lastshadow

To: Jenna who wrote (4727)	1/13/1998 11:02:00 PM
From: LastShadow	Read Replies (2) \| Respond to of 120523

A rare SHORT post... GERN - any free cash I come up with tomorrow goes to short GERN. The news: the company and the University of Texas Southwestern Medical Center at Dallas reported today the successful extension of the life-span of normal human cells using the enzyme telomerase. In a paper published in the journal Science, January 16, 1998, scientists explain that the introduction of an active telomerase gene into normal mortal cells resulted in the lengthening of telomeres and a marked increase in the life-span of the cells, making the cell potentially immortal. "The paper is a monumental advance in the understanding of the molecular genetics of aging... will likely have many important applications in the future of medicine and cell engineering..." Sounds great. Well, when the stock reopensed, the shares jumped 4+ points higher. However, history tells us (particurly the history of GERN), that this issue will come tumbling down on the next weak day in the market. The last time this happened was August 15, when the stock leapt more than 150% on news the company identified a protein key to the uncontrolled growth of cancer cells. If you had shorted then, you would have made as much as 50% on your money. Now there is a horrid thought - live forever. But hey, I am a tad contrarian... lastshadow